Who
Eric Crombez
Director
Company insider
Files Form 4 as: Director, Abeona Therapeutics; EVP and Chief Medical Officer, Ultragenyx Pharmaceutical; Chief Medical Officer, Dimension Therapeutics.
In numbers
- Trades disclosed
- 40
- Buys
- 0
- Sells
- 11
- Bought
- $0
- Sold
- $1.3M
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 1 Feb 2016
- Last trade
- 15 May 2026
- Last filed
- 15 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 May 2026filed 15 May 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $145K26,143 at $5.53 | filing |
| 15 May 2026filed 15 May 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $145K26,143 at $5.53 | filing |
| 5 May 2026filed 6 May 2026 | RARE Ultragenyx PharmaceuticalBiotechnology | SEC FORM 4 Sold | $8,586344 at $24.96 | filing |
| 5 May 2026filed 6 May 2026 | RARE Ultragenyx PharmaceuticalBiotechnology | SEC FORM 4 Sold | $8,586344 at $24.96 | filing |
| 16 Apr 2026filed 20 Apr 2026 | RARE Ultragenyx PharmaceuticalBiotechnology | SEC FORM 4 Code A | —34,674 at $0.00 | filing |
| 16 Apr 2026filed 20 Apr 2026 | RARE Ultragenyx Pharmaceuticaloption or derivative · Biotechnology | SEC FORM 4 Code A | —59,952 at $0.00 | filing |
| 16 Apr 2026filed 20 Apr 2026 | RARE Ultragenyx Pharmaceuticaloption or derivative · Biotechnology | SEC FORM 4 Code A | —59,952 at $0.00 | filing |
| 16 Apr 2026filed 20 Apr 2026 | RARE Ultragenyx PharmaceuticalBiotechnology | SEC FORM 4 Code A | —34,674 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | RARE Ultragenyx PharmaceuticalBiotechnology | SEC FORM 4 Sold | $160K7,029 at $22.80 | filing |
| 2 Mar 2026filed 3 Mar 2026 | RARE Ultragenyx PharmaceuticalBiotechnology | SEC FORM 4 Sold | $160K7,029 at $22.80 | filing |
| 1 Mar 2026filed 3 Mar 2026 | RARE Ultragenyx PharmaceuticalBiotechnology | SEC FORM 4 Code A | —11,643 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | RARE Ultragenyx PharmaceuticalBiotechnology | SEC FORM 4 Code A | —11,643 at $0.00 | filing |
| 2 Feb 2026filed 2 Feb 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $83K16,284 at $5.09 | filing |
| 2 Feb 2026filed 2 Feb 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $83K16,284 at $5.09 | filing |
| 26 Jan 2026filed 27 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —37,313 at $0.00 | filing |
| 26 Jan 2026filed 27 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —37,313 at $0.00 | filing |
| 14 Aug 2025filed 15 Aug 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $33K4,718 at $6.93 | filing |
| 5 May 2025filed 5 May 2025 | RARE Ultragenyx PharmaceuticalBiotechnology | SEC FORM 4 Sold | $20K520 at $39.24 | filing |
| 21 Apr 2025filed 5 May 2025 | RARE Ultragenyx PharmaceuticalBiotechnology | SEC FORM 4 Sold | $8,497242 at $35.11 | filing |
| 3 Mar 2025filed 4 Mar 2025 | RARE Ultragenyx PharmaceuticalBiotechnology | SEC FORM 4 Sold | $377K8,945 at $42.10 | filing |
News
Rep. Gilbert Ray Cisneros, Jr. Buys Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)RARE · themarketsdaily.com · 15 Oct 2026Ultragenyx (NASDAQ: RARE) agrees to sell PRV for $203 million in cashRARE · tickerreport.com · 14 Oct 2026
0 headlines in the last 90 days name Eric Crombez; 2 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.